HOME >> BIOLOGY >> NEWS
Proteasome activator enhances survival of Huntington's disease neuronal model cells

To function, each living cell needs both to build new and to degrade old or damaged proteins. To accomplish that, a number of intracellular systems work in concert to keep the cell healthy and from clogging up with damaged proteins. When proteins or peptides mutate, they can present major problems to the clearing up of the intracellular environment. In Huntington's disease (HD) the disease provoking mutation in the huntingtin gene eventually causes the cell to build up intranuclear and cellular inclusions of protein-aggregates, made up primarily of huntingtin. One cellular organelle with a central role of clearing such protein build up in the cell is the ubiquitin proteasome system (UPS).

In Huntington's disease (HD) brains and other tissues, UPS activity is inhibited and intraneuronal nuclear protein aggregates of mutant huntingtin in HD brains indicate dysfunction of the UPS. From these results, we hypothesized that enhancing UPS function would improve catalytic degradation of abnormal proteins in HD. We first genetically engineered proteasome activators involved in either non-ubiquitinated protein degradation pathways (PA28) or subunits of PA700, the 26S proteasome ubiquitinated pathway (S5a) into transducible lentiviral vectors. To address the therapeutic hypothesis experimentally, we transduced UPS subunits into HD skin fibroblasts or HD mutant protein expressing striatum-derived neurons. We determined how this intervention altered cell survival after exposure to toxins known to simulate pathological mechanisms in HD.

The manuscript shows that cellular changes due to expression of huntingtin protein with longer CAG repeats can reduce the ubiquitin proteasome system (UPS) function in Huntingtons disease cells. Following compromise of the UPS, the overexpression of proteasome activator PA28 can specifically recover proteasome function and improve cell viability in both HD model and patient cells.

These remarkable results demon
'"/>

Contact: Professor Ole Isacson
isacson@hms.harvard.edu
617-855-3243
Public Library of Science
27-Feb-2007


Page: 1 2

Related biology news :

1. Cancer drug enhances long-term memory
2. Dartmouth researchers identify a gene that enhances muscle performance
3. Getting ahead of cancer: SPECT/Spiral CT technology enhances bone scanning, earlier diagnosis
4. NYU algorithm enhances ability to detect cancer genes
5. Delft mathematician enhances protectiveness of military uniform
6. Elevated temperature enhances success of viral cancer therapy
7. Pulsating ultrasound enhances gene therapy for tumors
8. Moderate alcohol consumption enhances the formation of new nerve cells
9. New use for a cell toxin found to inhibit survival proteins in cancer cells
10. Glimmer of hope for Tahitian tree snails survival
11. Nexavar significantly extends overall survival by 44 percent in liver cancer patients

Post Your Comments:
(Date:5/21/2013)... at USC have found that a class of pharmaceuticals ... , The drugs, known as "TSPO ligands," are ... looked at the effects of TSPO ligand in young ... and in aged mice when pathology was quite severe," ... School of Gerontology. "TSPO ligand reduced measures of pathology ...
(Date:5/21/2013)... in pharmacies and health stores, phosphatidylserine is a ... soy. Proven to improve cognition and slow memory ... experiencing memory impairment. Now a team headed by ... Tel Aviv University,s Department of Human Molecular ... improves the functioning of genes involved in degenerative ...
(Date:5/21/2013)... CAMBRIDGE, MA -- Over the past few decades, scientists ... including angioplasty balloons and metallic stents. While generally effective, ... of side effects. , A new study from MIT ... combines the benefits of angioplasty balloons and drug-releasing stents, ... a balloon is inflated in the artery for only ...
Breaking Biology News(10 mins):Drugs found to both prevent and treat Alzheimer's disease in mice 2Common food supplement fights degenerative brain disorders 2Evaluating a new way to open clogged arteries 2Evaluating a new way to open clogged arteries 3
(Date:5/21/2013)... 2013 Savoury Systems International (SSI), a ... Braddy to Southeastern USA Sales Broker. Braddy’s new role ... in the Southeast. , In 2004 Braddy ... supplier to food processors and industrial manufacturers. Braddy ... food industry and has over 25 years of sales ...
(Date:5/21/2013)... As the R&D sector becomes increasingly ... industry to deliver better products, faster. Collaborations between ... often means turning big ideas into reality, within ... with Sensidose AB and Recipharm, is one example ... market sooner. The partnership resulted in the development ...
(Date:5/21/2013)... 2013  Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer ... infectious diseases, announced today that Jeffrey Riley ... Marcum LLP MicroCap Conference on Thursday, May 30, 2013 in ... Hyatt Hotel. Mr. Riley is scheduled to present at 10:00 ... Biologics, presentation can be accessed by logging onto the web ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 NANONEX ... nanoimprint solutions , today announced the successful delivery ... manufacturing system, the NX-M200B, to a major Japanese ... is a fully-automated, production-ready, advanced nanoimprint lithography tool ... of wafer and substrate sizes and types. Based ...
Breaking Biology Technology:The Development of an Innovative Microtablet Dosage Form, a Success Story: Live Webinar Hosted by Xtalks 2Synthetic Biologics to Present at the 2nd Annual Marcum LLP MicroCap Conference 2Nanonex Announces the Shipment and Installation of an Innovative Nanoimprint Lithography System for Fully Automated Manufacturing 2
Cached News: